Literature DB >> 24097666

The adaptive endoplasmic reticulum stress response to lipotoxicity in progressive human nonalcoholic fatty liver disease.

April D Lake1, Petr Novak, Rhiannon N Hardwick, Brieanna Flores-Keown, Fei Zhao, Walter T Klimecki, Nathan J Cherrington.   

Abstract

Nonalcoholic fatty liver disease (NAFLD) may progress from simple steatosis to severe, nonalcoholic steatohepatitis (NASH) in 7%-14% of the U.S. population through a second "hit" in the form of increased oxidative stress and inflammation. Endoplasmic reticulum (ER) stress signaling and the unfolded protein response (UPR) are triggered when high levels of lipids and misfolded proteins alter ER homeostasis creating a lipotoxic environment within NAFLD livers. The objective of this study was to determine the coordinate regulation of ER stress-associated genes in the progressive stages of human NAFLD. Human liver samples categorized as normal, steatosis, NASH (Fatty), and NASH (Not Fatty) were analyzed by individual Affymetrix GeneChip Human 1.0 ST microarrays, immunoblots, and immunohistochemistry. A gene set enrichment analysis was performed on autophagy, apoptosis, lipogenesis, and ER stress/UPR gene categories. An enrichment of downregulated genes in the ER stress-associated lipogenesis and ER stress/UPR gene categories was observed in NASH. Conversely, an enrichment of upregulated ER stress-associated genes for autophagy and apoptosis gene categories was observed in NASH. Protein expression of the adaptive liver response protein STC2 and the transcription factor X-box binding protein 1 spliced (XBP-1s) were significantly elevated among NASH samples, whereas other downstream ER stress proteins including CHOP, ATF4, and phosphorylated JNK and eIF2α were not significantly changed in disease progression. Increased nuclear accumulation of total XBP-1 protein was observed in steatosis and NASH livers. The findings reveal the presence of a coordinated, adaptive transcriptional response to hepatic ER stress in human NAFLD.

Entities:  

Keywords:  endoplasmic reticulum stress response mechanisms.; lipotoxicity; nonalcoholic fatty liver disease; nonalcoholic steatohepatitis

Mesh:

Substances:

Year:  2013        PMID: 24097666      PMCID: PMC3871931          DOI: 10.1093/toxsci/kft230

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  39 in total

Review 1.  Intracellular signaling from the endoplasmic reticulum to the nucleus: the unfolded protein response in yeast and mammals.

Authors:  C Patil; P Walter
Journal:  Curr Opin Cell Biol       Date:  2001-06       Impact factor: 8.382

2.  In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease.

Authors:  Anna Wieckowska; Nizar N Zein; Lisa M Yerian; A Rocio Lopez; Arthur J McCullough; Ariel E Feldstein
Journal:  Hepatology       Date:  2006-07       Impact factor: 17.425

Review 3.  Apoptosis and autophagy: regulatory connections between two supposedly different processes.

Authors:  Andrew Thorburn
Journal:  Apoptosis       Date:  2008-01       Impact factor: 4.677

4.  XBP1 controls diverse cell type- and condition-specific transcriptional regulatory networks.

Authors:  Diego Acosta-Alvear; Yiming Zhou; Alexandre Blais; Mary Tsikitis; Nathan H Lents; Carolina Arias; Christen J Lennon; Yuval Kluger; Brian David Dynlacht
Journal:  Mol Cell       Date:  2007-07-06       Impact factor: 17.970

5.  Steatohepatitis: a tale of two "hits"?

Authors:  C P Day; O F James
Journal:  Gastroenterology       Date:  1998-04       Impact factor: 22.682

6.  Design and validation of a histological scoring system for nonalcoholic fatty liver disease.

Authors:  David E Kleiner; Elizabeth M Brunt; Mark Van Natta; Cynthia Behling; Melissa J Contos; Oscar W Cummings; Linda D Ferrell; Yao-Chang Liu; Michael S Torbenson; Aynur Unalp-Arida; Matthew Yeh; Arthur J McCullough; Arun J Sanyal
Journal:  Hepatology       Date:  2005-06       Impact factor: 17.425

7.  Characterization of stanniocalcin 2, a novel target of the mammalian unfolded protein response with cytoprotective properties.

Authors:  Daisuke Ito; John R Walker; Charlie S Thompson; Isabella Moroz; William Lin; Margaret L Veselits; Antoine M Hakim; Allen A Fienberg; Gopal Thinakaran
Journal:  Mol Cell Biol       Date:  2004-11       Impact factor: 4.272

Review 8.  Pathophysiology of nonalcoholic steatohepatitis.

Authors:  Arthur J McCullough
Journal:  J Clin Gastroenterol       Date:  2006-03       Impact factor: 3.062

Review 9.  Molecular mechanisms and the role of saturated fatty acids in the progression of non-alcoholic fatty liver disease.

Authors:  Alexandra K Leamy; Robert A Egnatchik; Jamey D Young
Journal:  Prog Lipid Res       Date:  2012-11-23       Impact factor: 16.195

10.  pXBP1(U) encoded in XBP1 pre-mRNA negatively regulates unfolded protein response activator pXBP1(S) in mammalian ER stress response.

Authors:  Hiderou Yoshida; Masaya Oku; Mie Suzuki; Kazutoshi Mori
Journal:  J Cell Biol       Date:  2006-02-06       Impact factor: 10.539

View more
  48 in total

Review 1.  Endoplasmic reticulum stress as the basis of obesity and metabolic diseases: focus on adipose tissue, liver, and pancreas.

Authors:  Aline Fernandes-da-Silva; Carolline Santos Miranda; Daiana Araujo Santana-Oliveira; Brenda Oliveira-Cordeiro; Camilla Rangel-Azevedo; Flávia Maria Silva-Veiga; Fabiane Ferreira Martins; Vanessa Souza-Mello
Journal:  Eur J Nutr       Date:  2021-03-19       Impact factor: 5.614

2.  Development of gene polymorphisms in meditators of nonalcoholic fatty liver disease.

Authors:  Chun Wang; Jianping Gong; Hao Wu
Journal:  Biomed Rep       Date:  2017-06-14

3.  Hepatocyte X-box binding protein 1 deficiency increases liver injury in mice fed a high-fat/sugar diet.

Authors:  Xiaoying Liu; Anne S Henkel; Brian E LeCuyer; Matthew J Schipma; Kristy A Anderson; Richard M Green
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-10-15       Impact factor: 4.052

4.  Alcoholic steatohepatitis (ASH) causes more UPR-ER stress than non-alcoholic steatohepatitis (NASH).

Authors:  M Masouminia; S Samadzadeh; A Ebaee; B A French; B Tillman; S W French
Journal:  Exp Mol Pathol       Date:  2016-08-29       Impact factor: 3.362

Review 5.  Mitogen-Activated Protein Kinase Regulation in Hepatic Metabolism.

Authors:  Ahmed Lawan; Anton M Bennett
Journal:  Trends Endocrinol Metab       Date:  2017-11-08       Impact factor: 12.015

Review 6.  Developmental origins of nonalcoholic fatty liver disease as a risk factor for exaggerated metabolic and cardiovascular-renal disease.

Authors:  Frank T Spradley; Jillian A Smith; Barbara T Alexander; Christopher D Anderson
Journal:  Am J Physiol Endocrinol Metab       Date:  2018-03-06       Impact factor: 4.310

Review 7.  Caring for children with NAFLD and navigating their care into adulthood.

Authors:  Ali A Mencin; Rohit Loomba; Joel E Lavine
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-09-01       Impact factor: 46.802

8.  Decreasing mitochondrial fission alleviates hepatic steatosis in a murine model of nonalcoholic fatty liver disease.

Authors:  Chad A Galloway; Hakjoo Lee; Paul S Brookes; Yisang Yoon
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-07-31       Impact factor: 4.052

9.  IRE1α prevents hepatic steatosis by processing and promoting the degradation of select microRNAs.

Authors:  Jie-Mei Wang; Yining Qiu; Zhao Yang; Hyunbae Kim; Qingwen Qian; Qinghua Sun; Chunbin Zhang; Lei Yin; Deyu Fang; Sung Hong Back; Randal J Kaufman; Ling Yang; Kezhong Zhang
Journal:  Sci Signal       Date:  2018-05-15       Impact factor: 8.192

Review 10.  Molecular mechanisms of lipotoxicity and glucotoxicity in nonalcoholic fatty liver disease.

Authors:  Manoela Mota; Bubu A Banini; Sophie C Cazanave; Arun J Sanyal
Journal:  Metabolism       Date:  2016-03-03       Impact factor: 8.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.